Monday, April 10, 2023 7:20:45 AM
Every doctor who "signed" the Jama paper had a conflict of interest. Most were barely involved in the trial but were probably at the hospital where the trial happened and might have taken a patients blood so they wanted a publication credit. The majority of sites saw zero improvement based on simple math in their miniscule number of patients in the trial despite the cherry picking. The majority of sites in the trial had less than 5 patients. Many had one or two.
Patient level data, which they have for the P3 but won't release, would show this. Patient level data is also what LL said would be need to show efficacy, and the don't have that for the ECA.
Trying to discredit ACTUAL oncologists who disagree with this farce of a trial is character assassination pure and simple. It's all longs have since they actually paid Stupp for consultation and he said the data sucked, just like any doctor not shilling for the company by getting their little mention on the bullshit data paper.
Patient level data, which they have for the P3 but won't release, would show this. Patient level data is also what LL said would be need to show efficacy, and the don't have that for the ECA.
Trying to discredit ACTUAL oncologists who disagree with this farce of a trial is character assassination pure and simple. It's all longs have since they actually paid Stupp for consultation and he said the data sucked, just like any doctor not shilling for the company by getting their little mention on the bullshit data paper.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
